News

AddToAny

Google+ Facebook Twitter Twitter

Blood health awareness

The IBMS has been involved in a new campaign organised by Media Planet to promote blood health awareness. 
 

Red-blood-cells-_iStock-182860171

In collaboration with professional bodies, including the IBMS, Cancer Research UK and The Royal College of Pathologists, MediaPlanet promoted awareness in a print and digital campaign.

This campaign promoted new developments in research, programmes, and therapy initiatives for patients with blood- and cancer-related health issues. 

Featured were two articles demonstrating the thrombosis research of IBMS Fellow and Chief Examiner in Haematology Dr Gary Moore, and the Mobile Chemotherapy Unit initiative launched by Hope for Tomorrow charity and the pathology staff at East Kent Hospitals University NHS Foundation Trust, including IBMS Fellow Catherine Lorenzen.

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top